Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurtzke, J. F.
Right arrow Articles by Hyllested, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurtzke, J. F.
Right arrow Articles by Hyllested, K.
NEUROLOGY 1986;36:307
© 1986 American Academy of Neurology

Multiple sclerosis in the Faroe Islands.

II. Clinical update, transmission, and the nature of MS

John F. Kurtzke, MD and Kay Hyllested, DrMed

Neuroepidemiology Research Program and the Neurology Service, Veterans Administration Medical Center, and the Departments of Neurology and Community Medicine, Georgetown University School of Medicine, Washington, DC (Dr. Kurtzke); and the Department of Neurology, Roskilde County Hospital, Roskilde, and the Danish MS Registry, Copenhagen, Denmark (Dr. Hyllested).

In this century, 41 Faroese with MS were ascertained. One subset, after living in Denmark for 2 years between ages 11 and 31, had MS onset an average of 6 years later. In the Faroes, MS occurred as three separate and decreasing epidemics beginning in 1943 and ending in 1973. We believe that asymptomatic British troops introduced the first epidemic during 1941 to 1942, with the later epidemics resulting from transmission by affected but asymptomatic Faroese. We conclude that "MS" is a widespread, systemic, specific infectious disease only rarely causing neurologic symptoms and transmissible at most from ages 13 to 26.

Address correspondence and reprint requests to Dr. Kurtzke, Neurology 127, VA Medical Center, 50 Irving Street, NW, Washington, DC 20422.

Presented in part at the 1981 Asian Multiple Sclerosis Workshop, Kyoto, Japan, September 1981; the annual meeting of the American Epidemiological Society, Kansas City, MO, April 1982; the Silver Jubilee Conference on Multiple Sclerosis, Copenhagen, Denmark, June 1982; and the meeting of the WFN Research Committee on Neuroepidemiology, Dallas, TX, May 1985.

Supported by the National Multiple Sclerosis Society (New York), the Veterans Administration (Neuroepidemiology Research Program), and the Danish MS Society.

Accepted for publication June 21, 1985.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
M. Pugliatti, T. Riise, M. A. Sotgiu, W. M. Satta, S. Sotgiu, M. I. Pirastru, and G. Rosati
Evidence of Early Childhood as the Susceptibility Period in Multiple Sclerosis: Space-Time Cluster Analysis in a Sardinian Population
Am. J. Epidemiol., August 15, 2006; 164(4): 326 - 333.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. R. Hammond, D. R. English, and J. G. McLeod
The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia
Brain, May 1, 2000; 123(5): 968 - 974.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Inoue, C.-S. Koh, M. Yamazaki, and H. Yagita
Effect of Anti-B7-1 and Anti-B7-2 mAb on Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease
J. Immunol., December 1, 1999; 163(11): 6180 - 6186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. E. Smith, N. L. Eller, H. F. McFarland, M. K. Racke, and C. S. Raine
Age Dependence of Clinical and Pathological Manifestations of Autoimmune Demyelination : Implications for Multiple Sclerosis
Am. J. Pathol., October 1, 1999; 155(4): 1147 - 1161.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Inoue, C.-S. Koh, M. Yamazaki, H. Yahikozawa, M. Ichikawa, H. Yagita, and B. S. Kim
Suppressive Effect on Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease by the Administration of Anti-IL-12 Antibody
J. Immunol., November 15, 1998; 161(10): 5586 - 5593.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P M Rothwell and D Charlton
High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition
J. Neurol. Neurosurg. Psychiatry, June 1, 1998; 64(6): 730 - 735.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. S Brown Jr
Geographic correlation of multiple sclerosis with tick-borne diseases
Multiple Sclerosis, April 1, 1996; 1(5): 257 - 261.
[Abstract] [PDF]


Home page
Arch NeurolHome page
Z.-x. Zhang, D. W. Anderson, L. Lavine, and N. Mantel
Patterns of Acquiring Parkinsonism-Dementia Complex on Guam: 1944 Through 1985
Arch Neurol, September 1, 1990; 47(9): 1019 - 1024.
[Abstract] [PDF]


Home page
Arch NeurolHome page
S. B. Elias
Oligodendrocyte Development and the Natural History of Multiple Sclerosis: A New Hypothesis for the Pathogenesis of the Disease
Arch Neurol, December 1, 1987; 44(12): 1294 - 1299.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.